Is MGTX above its 150-day moving average?

MGTX is currently above its 150-day moving average by 26.94%. The MA150 sits at $8.39.

What is MGTX's RSI right now?

MGTX's 14-period RSI is 62.2. This is in a neutral zone (30–70).

Is MGTX's MACD bullish or bearish?

MGTX's MACD histogram reads +0.0551. A positive histogram means short-term momentum is leaning bullish.

How are MGTX's technical signals calculated?

Scanance computes MGTX's technicals daily after market close from end-of-day OHLCV data. MA150 and MA200 are simple moving averages. RSI uses Wilder's 14-period smoothing. MACD uses 12/26/9 exponential moving averages. Volume ratio compares current volume to the 20-day average.

Scanance does not provide investment advice. The technical readouts on this page are pattern matches against deterministic indicator rules — they are not buy or sell recommendations. Always do your own research and consider consulting a licensed financial professional before making any trade.

MG

MeiraGTx Holdings plc

MGTXHealthcareNASDAQ

Biotechnology · Last scanned Jun 1, 2026

PriceMA150MA200

Loading chart…

End-of-day data · ScananceOpen live chart on TradingView ↗

Indicator snapshot · Today

Premium

Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →

Financials · Annual

Revenue

$81.4M

+144.6% YoY

Net Income

-$114.2M

+22.7% YoY

EBITDA

-$89.4M

+26.6% YoY

Free Cash Flow

$45.0M

Scan Results

Daily timeframe

DateIndicatorDetails

About MeiraGTx Holdings plc

Part of the healthcare sector, MeiraGTx Holdings plc (MGTX) is listed under Biotechnology. The company carries a $986.3M market cap, placing it firmly in the small-cap category. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases; neurodegenerative diseases; and xerostomia.

Key stats

Market Cap$986.3M

Fwd P/E-7.65

EPS$-1.48

Beta1.24

52W Change+95.0%

Analysis

On the balance sheet, MGTX has $71.5M in cash with $87.5M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $45.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Revenue has grown from $15.9M (2022) to $81.4M (2025), reflecting a 411% increase over the period.

Investors considering MeiraGTx Holdings plc should weigh the typical risks associated with MGTX's sector, size, and financial profile against their own risk tolerance and investment objectives. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for MeiraGTx Holdings plc and its sector.

Links

Company website ↗

MeiraGTx Holdings plc

News & analytics is part of Premium.

Technical readouts are part of Premium.